Advertisement

Topics

Latest "Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis" News Stories

02:26 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis" found in our extensive news archives from over 250 global news sources.

More Information about Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis for you to read. Along with our medical data and news we also list Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis Clinical Trials, which are updated daily. BioPortfolio also has a large database of Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis Companies for you to search.

Showing "Thermography Assessing Treatment Response Golimumab Psoriatic Arthritis" News Articles 1–25 of 19,000+

Saturday 20th October 2018

IsoRay Inc ISR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryIsoRay Inc IsoRay, formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotopebased personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium131, a radioactive isotope used in brachytherapy for the treatment of prostate, brain, lung, head, neck and gynec...


TaiMed Biologics Inc 4147 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryTaiMed Biologics Inc TMB is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB355, TMB607 and TMB571, among others. It offers TMB355 which is a proprietary humanized antiCD4 monoclonal antibody, developed for the treatment of HIV, and others. TMB provides TMB607 which is a no...

Paranta Biosciences Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryParanta Biosciences Ltd Paranta Biosciences is a biopharmaceutical company that develops biotherapeutics for the treatment of inflammatory and fibrotic diseases. The company develops product candidate PB01, a recombinant human follistatin288 used for the treatment of cystic fibrosis lung disease. Paranta Biosciences also develops PB01 as chemotherapysensitizing agent for the treatment of no...


Friday 19th October 2018

Spain Dental Polishing Procedures Outlook to 2025 [Report Updated: 01092018] Prices from USD $2995

Spain Dental Polishing Procedures Outlook to 2025SummaryGlobalData's new report, Spain Dental Polishing Procedures Outlook to 2025, provides key procedures data on the Spain Dental Polishing Procedures. The report provides procedure volumes within market segment Dental Polishing Procedures.The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based mo...

Australia Airway and Anesthesia Procedures Outlook to 2025 [Report Updated: 01102018] Prices from USD $2995

Australia Airway and Anesthesia Procedures Outlook to 2025SummaryGlobalData's new report, Australia Airway and Anesthesia Procedures Outlook to 2024, provides key procedures data on the Australia Airway and Anesthesia Procedures. The report provides procedure volumes within market segments Airway Management Procedures, Anesthesia Circuit Procedures, Anesthesia Mask Procedures, Breathing Bag Proce...

Florida Hospital and the Tampa Bay Buccaneers Take on Breast Cancer

The 6th annual Treasure Chests 5K + Fun Run supports breast cancer research in Tampa Bay. TAMPA, Fla. (PRWEB) October 19, 2018 Florida Hospital, soon to be AdventHealth, the Exclusive Hospital of the Tampa Bay Buccaneers, and title sponsor of AdventHealth Training Center, is excited once again to be part of the Sixth Annual Treasure Chests 5K + Fun Run, powered by Jabil. The race celebrates breas...

United States Dental Procedures Outlook to 2025 Crown and Bridge Procedures, Dental Implant Procedures, Dental Membrane Procedures and Dental Polishing Procedures [Report Updated: 10092018] Prices from USD $3995

United States Dental Procedures Outlook to 2025 Crown and Bridge Procedures, Dental Implant Procedures, Dental Membrane Procedures and Dental Polishing ProceduresSummaryGlobalData's new report, United States Dental Procedures Outlook to 2025, provides key procedures data on the United States Dental Procedures. The report provides procedure volumes within market categories Crown and Bridge Proced...

Ascletis's Second HCV Treatment on Priority Review List in China

Ascletis Pharma of Hangzhou reported that its second hepatitis C treatment, ravidasvir, has been included in China's list of Proposed Priority Review drugs. Ascletis has submitted an NDA for ravidasvir, a China Category 1 candidate, as part of a two-drug combination treatment, along with already-approved Ganovo®. The combination, an all-oral interferon-free regimen, produced a 99% cure rate in...

Valbiotis SAS ALVAL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryValbiotis SAS Valbiotis is a biotechnology company that develops novel solutions to help prevent cardiometabolic diseases, besides nutrition products. It develops solutions to prevent type 2 diabetes, nonalcoholic steatohepatitis NASH, obesity and cardiovascular diseases. The company has three products under development based on the active ingredient TOTUM63. They include Valedia, indicated...

Qfix® Revolutionizes Adaptive Thermoplastic Masks for Intracranial, Head and Neck Cancer Treatment

AVONDALE, Pa., Oct. 19, 2018 /PRNewswire/ -- Qfix introduces a new line of thermoplastic masks for fractionated intracranial head and neck cancer treatments. Over the Read more...

Bipolar Depression and Lurasidone: What C-Reactive Protein Levels Can Tell Us About Response

Responses to both high or low lurasidone doses were linearly related to baseline CRP levels.

Italy Dental Polishing Procedures Outlook to 2025 [Report Updated: 01092018] Prices from USD $2995

Italy Dental Polishing Procedures Outlook to 2025SummaryGlobalData's new report, Italy Dental Polishing Procedures Outlook to 2025, provides key procedures data on the Italy Dental Polishing Procedures. The report provides procedure volumes within market segment Dental Polishing Procedures.The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based mo...

Mereo Biopharma Group Plc MPH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryMereo Biopharma Group Plc Mereo, formerly Mereo Biopharma Group Ltd is a specialty biopharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company's pipeline products include BPS804, which is used for the treatment of brittle bone syndrome; and BCT197, an orally active p38 MAP kinase inhibitor developed for acute exacerbations of chroni...

MyoKardia Inc MYOK Financial and Strategic SWOT Analysis Review [Report Updated: 12092018] Prices from USD $125

MyoKardia Inc MYOK Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your bu...

DanaFarber Cancer Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryDanaFarber Cancer Institute Inc DanaFarber, formerly Sidney Farber Cancer Center is a cancer research center that offers treatment for different types of cancers. The center offers adults and children with various treatment options and also focuses on diagnosis, treatment, cure, and prevention of cancer and related diseases. The institute has many ongoing clinical trials for cancer at DanaF...

SI-BONE Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' ...

SANTA CLARA, Calif., Oct. 19, 2018 /PRNewswire/ -- SI-BONE, Inc. (Nasdaq: SIBN) ("SI-BONE"), a medical device company that pioneered the minimally invasive surgical treatment of Read more...

T3D Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryT3D Therapeutics Inc T3D Therapeutics is a drug discovery company that develops solutions for the treatment of Alzheimer's disease and Mild Cognitive Impairment. The company's pipeline product include T3D959 an optimal disease remedial therapeutic for the treatment of Alzheimer's disease. It provides a potential to improve dysfunctional glucose and lipid metabolism that is inherent in other...

Bristol-Myers Squibb Provides Update on the Ongoing Regulatory Review of Opdivo Plus Low-Dose Yervoy in First-Line Lung Cancer Patients with Tumor Mutational Burden ≥10 mut/Mb

New analysis submitted to U.S. Food and Drug Administration (FDA) constitutes a major amendment to the Company’s supplemental Biologics License Application (sBLA) Bristol-Myers Squibb Company (NYSE:BMY) announced updates regarding regulatory actions by health authorities in the Un

Neurolixis Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryNeurolixis Inc Neurolixis is an earlystage biopharmaceutical company that discovers and develops novel drugs for the treatment of human central nervous system disorders. The company's pipeline product portfolio comprises NLX112, a drug candidate intended for the treatment of LDOPAinduced dyskinesia; and NLX101 is a drug used for the treatment of breathing difficulties in Rett's syndrome, a ...

The Walter and Eliza Hall Institute of Medical Research Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryThe Walter and Eliza Hall Institute of Medical Research WEHI, a subsidiary of Melbourne Medical School The University of Melbourne is a medical research institute that conducts clinical research, and offers educational and contract research services. The institute develops therapeutics for the prevention and treatment of diseases including breast, ovarian and blood cancers, type 1 diabetes,...

OncoSil Medical Ltd OSL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryOncoSil Medical Ltd OncoSil, formerly Neuro Discovery Ltd, is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company's lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous tumor during an endoscopic ultrasound guidance procedure. It offers vario...

$5.1 Million Grant Will Fund Research to Develop a Stem Cell-Based Therapy for Blinding Eye Condition

NewsThe treatment that will use patients' own skin cells to generate autologous induced pluripotent stem cells to derive retinal pigment epithelium cells.

AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting

REDWOOD CITY, Calif., Oct. 19, 2018 /PRNewswire/ -- In response to opinions expressed following the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Read more...

Scilex Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryScilex Pharmaceuticals Inc Scilex Pharma, a subsidiary of Sorrento Therapeutics Inc is a developer of pharmaceutical products. The company develops and commercializes branded pharmaceutical products for the treatment of pain. Its technologies include drug delivery and proprietary patch technologies. Scilex Pharma's lead product under development, ZTlido, a lidocaine patch formulation for th...

“A spectacular milestone in the history of medicine,” says $CLLS Cellectis CEO André Choulika, on $SGMO Sangamo #genomeediting trial, but investor response diminishes its significance https://rdcu.be/81MN pic.twitter.com/3Yb84AL6J6

“A spectacular milestone in the history of medicine,” says $CLLS Cellectis CEO André Choulika, on $SGMO Sangamo #genomeediting trial, but investor response diminishes its significance https://rdcu.be/81MN  pic.twitter.com/3Yb84AL6J6


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks